Equilab International
Equilab International is a leading Contract Research Organization (CRO) based in Indonesia and Southeast Asia since 2003, providing comprehensive clinical research services including bioavailability/bioequivalence studies, clinical trials, laboratory testing, and dermatology testing. The company supports global pharmaceutical and biotech clients with over 1,500 completed projects and more than 100 international clients. Equilab's clinical study reports are accepted in over 40 countries, including regulatory bodies such as WHO and UK-MHRA. It is accredited by UK MHRA, Malaysian NPRA, BPOM, ISO 17025, and ISO 15189, ensuring high quality and regulatory compliance. Equilab offers specialized expertise in various dosage forms and therapeutic areas, leveraging Indonesia's large and diverse population for efficient clinical trial recruitment. The company also innovates with AI to enhance research and testing efficiency.
Equilab International
Equilab International is a leading Contract Research Organization (CRO) based in Indonesia and Southeast Asia since 2003, providing comprehensive clinical research services including bioavailability/bioequivalence studies, clinical trials, laboratory testing, and dermatology testing. The company supports global pharmaceutical and biotech clients with over 1,500 completed projects and more than 100 international clients. Equilab's clinical study reports are accepted in over 40 countries, including regulatory bodies such as WHO and UK-MHRA. It is accredited by UK MHRA, Malaysian NPRA, BPOM, ISO 17025, and ISO 15189, ensuring high quality and regulatory compliance. Equilab offers specialized expertise in various dosage forms and therapeutic areas, leveraging Indonesia's large and diverse population for efficient clinical trial recruitment. The company also innovates with AI to enhance research and testing efficiency.